Tactoset Injectable Bone Substitute
K-Number: K212083 · 2021-08-31
ApplicantAnika Therapeutics, Inc.
Decision Date2021-08-31
Product CodeMQV
Advisory CommitteeOR
DecisionSubstantially Equivalent
Device Summary
Tactoset Injectable Bone Substitute is a medical device manufactured by Anika Therapeutics, Inc.. It received FDA 510(k) clearance on 2021-08-31 under approval number K212083. The device is classified under product code MQV. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Tactoset Injectable Bone Substitute?
Tactoset Injectable Bone Substitute is a medical device that received FDA 510(k) clearance on 2021-08-31. It is manufactured by Anika Therapeutics, Inc.. The 510(k) number is K212083.
When was Tactoset Injectable Bone Substitute approved by the FDA?
Tactoset Injectable Bone Substitute received FDA 510(k) clearance on 2021-08-31, under approval number K212083.
What company makes Tactoset Injectable Bone Substitute?
Tactoset Injectable Bone Substitute is manufactured by Anika Therapeutics, Inc..
What is the FDA product code for Tactoset Injectable Bone Substitute?
The FDA product code for Tactoset Injectable Bone Substitute is MQV.
Other Devices by Anika Therapeutics, Inc.
Related Devices (Code: MQV)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.